YIDU TECH (02158.HK) Latest News & Headlines | Longbridge

© 2026 Longbridge｜Terms of Service Privacy Policy

Yidu Tech Unit Wins RMB8.6 Million Hospital IT Infrastructure Contract
Tip Ranks·Aug 9 at 11:38 PM
- Yidu Cloud won a contract valued at about RMB 8.6 million to build IT infrastructure for the Tongzhou campus of Capital Children’s Medical Center. - The project underscores Yidu Tech’s growing role in modernizing hospital infrastructure and supports its AI-driven healthcare upgrade strategy. - This contract reinforces the company's position as a key technology partner for major medical institutions in China.
02158-0.66%
Yidu Tech Sets AGM to Approve Dividend, Board Mandates and Share-Issuance Authority
Tip Ranks·Jul 24 at 06:09 AM
- Yidu Tech, Inc. has scheduled its annual general meeting for August 28, 2026, in Beijing to review financial statements and vote on a proposed dividend. - The agenda includes re-electing two directors, renewing PricewaterhouseCoopers as auditor, and granting the board authority for share issuance, capped at 20% of issued share capital. - This will enable Yidu Tech to manage its capital structure and governance effectively while adhering to market practices.
02158-0.66%
Yidu Tech announces annual general meeting notice
PUBT·Jul 24 at 05:31 AM
- Yidu Tech will hold its annual general meeting in Beijing on August 28, 2026, regarding the fiscal year ending March 31, 2026. - Shareholders will vote on a final dividend of HKD 0.04 per share, totaling around HKD 40.8 million, alongside mandates for share issuance and buybacks. - The meeting will also include the re-election of directors Ma Wei-Ying and Pan Rongrong, the retirement of Zeng Ming, and the reappointment of PricewaterhouseCoopers as auditors with a fee of approximately RMB 4.95 million.
02158-0.66%
Yidu Tech publishes 2026 annual report
PUBT·Jul 24 at 05:27 AM
- Yidu Tech's annual report indicates a shift to full-year profitability in FY2026 due to higher-margin delivery and cost control. - The company expanded AI for Medical deployments in major hospitals and strengthened partnerships with drugmakers for clinical research. - Additionally, AI for Care enhanced insurance services and accelerated digital therapeutics in primary care, while the board proposed a dividend of HK$ 0.04 per share.
02158-0.66%
Yidu Tech Achieves Its First Full-Year Profit: FY2026 Net Profit Reaches RMB 78.8 Million, with Positive Operating Cash Flow in the Second Half
PR Newswire·Jul 2 at 04:14 AM
- Yidu Tech reported its first full-year profitability for FY2026, with a net profit of RMB 78.8 million and total revenue rising 14.6% to RMB 820 million. - The company’s AI for Care segment showed the strongest growth at 37.6%, while its proprietary platform, YiduCore, processed nearly 9 billion medical records to enhance AI capabilities. - Looking ahead, Yidu Tech aims to expand its healthcare AI ecosystem, focusing on scalable integration and commercial opportunities across various healthcare sectors.
02158-0.66%
Yidu Tech proposes final dividend of HKD 0.04 per share for FY ended March 31, 2026
PUBT·Jun 29 at 05:38 PM
- Yidu Tech proposed a final dividend of HKD 0.04 per share for the year ending March 31, 2026. - Shareholders will vote on the proposal on August 28, with shares trading ex-dividend on September 1. - The dividend payment is scheduled for September 16, with record holders as of September 7 qualifying for the payout.
02158-0.66%
Yidu Tech Turns Profitable as Medical AI Business Accelerates
Tip Ranks·Jun 29 at 05:37 PM
- Yidu Tech, Inc. reported a significant advancement in the global medical AI sector, highlighting its comprehensive AI solutions and a strong YiduCore platform. - For the fiscal year ending on March 31, 2026, the company achieved a revenue of RMB 819.3 million, growing by 14.6% year on year, and recorded a net profit of RMB 78.8 million, marking a turnaround in financial performance. - This growth was driven by increases across AI segments, particularly a 37.6% rise in AI for Care, alongside improved cash flow and the proposal of a final cash dividend.
02158-0.66%
Yidu Tech Declares Final Cash Dividend for FY2026
Tip Ranks·Jun 29 at 05:37 PM
- Yidu Tech, Inc. has announced a final ordinary cash dividend of HKD 0.04 per share for the fiscal year ending 31 March 2026, with payment planned for 16 September 2026, pending shareholder approval. - The ex-dividend date is 1 September 2026, and the book closure period will be from 3 to 7 September 2026, establishing the eligibility for shareholders. - This dividend distribution demonstrates management's confidence in the company's financial position and aligns with standard Hong Kong practices, with no withholding tax applying to the payout.
02158-0.66%
Yidu Tech swings to FY26 profit of RMB 78.77 million; revenue rises 14.6% to RMB 819.3 million
PUBT·Jun 29 at 05:31 PM
- Yidu Tech reported revenue of RMB 819.3 million, a 14.6% increase year over year, achieving a profit of RMB 78.8 million. - Operating profit rose to RMB 87.8 million, and gross margin improved by 2.9 percentage points to 36.4%. - AI for Care and AI for Medical revenues increased by 37.6% and 10.2%, respectively, while a final dividend of HK$ 0.04 per share was announced.
02158-0.66%
Yidu Tech postpones board meeting on annual results release
PUBT·Jun 28 at 06:30 PM
- Yidu Tech will hold its postponed board meeting on June 30, 2026, to review the audited annual results for the year ended March 31, 2026. - The meeting was rescheduled from June 28, 2026, due to a slight delay in the annual audit completion. - The content was generated by Public Technologies and is intended for informational purposes, not as financial, investment, or legal advice.
02158-0.66%
Biotech Firms Push Weight-Loss and AI Pipelines Amid Buyback Wave
Global Report·Jun 27 at 04:04 AM
- The Hong Kong stock market's healthcare sector is accelerating the commercialization of weight loss pipelines and medical AI, with leading companies repurchasing shares worth over hundreds of millions of Hong Kong dollars to stabilize market expectations. - Hansoh Pharma has initiated a Phase III trial for its oral GLP-1/GIP project and formed a collaboration worth over $1 billion with Bristol-Myers Squibb, while other firms like Innovent Biologics are expanding revenue through new drug approvals. - Despite challenges such as shareholder dissent on capital allocation, key companies are countering macro uncertainties through overseas clinical registrations and intensive buybacks, focusing capital on firms with substantive commercialization progress.
01276-2.14%01801-0.42%
Yidu Tech chair Gong Yingying speaks at Summer Davos panel on faster drug access
PUBT·Jun 24 at 04:31 AM
- Yidu Tech participated in the Summer Davos 2026 event in Dalian, focusing on drug development speed and access. - Chair Gong Yingying presented a strategy using the YiduCore platform aimed at enhancing trial design, recruitment, monitoring, and real-world evidence. - This summary is based on information generated by Public Technologies, which emphasizes that it's for informational purposes only and not financial or legal advice.
02158-0.66%
HK Healthcare & Consumer Roundup: AI Monetization Accelerates as SaaS Firms Pivot to Profit
Global Report·Jun 24 at 04:13 AM
- The Hong Kong stock market is witnessing a fundamental reassessment of the new consumer and health industries. - Leading companies, like Ping An Good Doctor and Yidu Tech, are showing significant financial improvements, with notable revenue growth and profitability driven by advances in AI and strategic shifts. - Mengniu Dairy is also restructuring its asset quality by repurchasing shares to enhance market liquidity and confidence amid evolving consumer dynamics.
01833-2.14%02158-0.66%
Yidu Tech reschedules board meeting on annual results release
PUBT·Jun 22 at 09:45 AM
- Yidu Tech has rescheduled its board meeting to June 28, 2026, to finalize audited annual results for the year ended March 31, 2026. - The meeting was originally planned for June 22, 2026, and the board will also review a final dividend. - This update was generated by Public Technologies and is intended for informational purposes only, not as financial or legal advice.
02158-0.66%
High Growth Tech Stocks Including Yidu Tech with Promising Potential
Simplywall·Jun 1 at 04:15 AM
- Global markets have shifted positively, driven by hopes for a U.S.-Iran peace deal and strong performance in AI-linked stocks, especially the Nasdaq Composite. - High-growth tech companies, such as Yidu Tech and Linklogis, show promising recovery and potential for future profitability, with Yidu Tech projecting profits and Linklogis reducing its net loss while focusing on innovation. - Beijing Enlight Media anticipates significant revenue growth and profitability within three years, despite recent challenges in the entertainment sector.
02158-0.66%09959+2.98%